The French Tech Journal
frenchtechjournal.com
Actively hiring
Venture Capital
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Independent news and analysis on French startups, AI, venture capital and funding, with deep dives, data, interviews and original reporting in English.
News
Essential Summer Reads #3: AI Is Making Silicon Valley Startups Leaner and Meaner. Can French Founders Keep Up?
Throughout August, we're revisiting eight long-form FTJ articles from the past year whose themes continue to resonate. From AI and deeptech to sovereignty, cybersecurity and global scale, they explore the ideas, companies and debates shaping French Tech.
Read more
Report
Essential Summer Reads #2: Nuclear Meltdown: How NAAREA Burned Through €90 Million and Collapsed in Spectacular Fashion
Throughout August, we're revisiting eight long-form FTJ articles whose themes continue to resonate today. From AI and deeptech to sovereignty, cybersecurity and global scale, they explore the ideas, companies and debates shaping French Tech. We hope you e
Read more
Report
Essential Summer Reads #1: How Juisci Is Using AI to Save Doctors 8 Hours a Week and Fight Medical Misinformation
Throughout August, we're revisiting eight long-form FTJ articles whose themes continue to resonate today. From AI and deeptech to sovereignty, cybersecurity and global scale, they explore the ideas, companies and debates shaping French Tech. We hope you e
Read more
Report
French Tech Wire: Nanobiotix's $6 Billion Physics Bet
Inside this week's edition: Can physics transform cancer treatment and also generate $6 billion in annual sales? Nanobiotix CEO Laurent Lévy believes so. In an exclusive interview, he explains why the company's physics-based approach could underpin a new
Read more
Report
Nanobiotix's Laurent Lévy: "We're creating a new class of medicines and a potential $6bn blockbuster."
For most biotech companies, the challenge is biological: discovering a new molecule capable of changing the course of disease. Nanobiotix's founders believe that in some cases the answer is physics, not biology.That conviction has shaped the Paris-based c
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.